Drugs / EVONAIL® solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02670603 | Aug 2015 → Jun 2016 | breast cancer | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVONAIL solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02670603 ↗ |
| Known as | HNS | “HNS (EVONAIL® solution, Evaux Laboratories, France)” PMID 28488142 ↗ May 2017 |
| Route | Topical | “patients painted HNS on nails and periungual areas once a day till developing onycholysis grade 2.” PMID 28488142 ↗ May 2017 |